Heterogeneous treatment effects in stratified clinical trials with time‐to‐event endpoints (Q5348691): Difference between revisions
From MaRDI portal
ReferenceBot (talk | contribs) Changed an Item |
Normalize DOI. |
||
| Property / DOI | |||
| Property / DOI: 10.1002/bimj.201600047 / rank | |||
| Property / DOI | |||
| Property / DOI: 10.1002/BIMJ.201600047 / rank | |||
Normal rank | |||
Latest revision as of 16:44, 30 December 2024
scientific article; zbMATH DE number 6762403
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Heterogeneous treatment effects in stratified clinical trials with time‐to‐event endpoints |
scientific article; zbMATH DE number 6762403 |
Statements
Heterogeneous treatment effects in stratified clinical trials with time‐to‐event endpoints (English)
0 references
18 August 2017
0 references
biomarkers
0 references
Cox proportional hazards model
0 references
log-rank test
0 references
sample size
0 references
shared frailty model
0 references
trial design
0 references
